Actinium Pharmaceuticals, Inc. (ATNM) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$90.0K

Net Income/Loss (FY2025)

-$33.9M

Total Assets (FY2025)

$51.8M

Total Equity (FY2025)

$7.8M

Cash Flows from Operating Activities (FY2025)

-$24.6M

Source: Actinium Pharmaceuticals, Inc. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.